Trevena Inc (NAS:TRVN)
$ 6.7 -0.79 (-10.55%) Market Cap: 5.71 Mil Enterprise Value: 26.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Q1 2021 Trevena Inc Earnings Call Transcript

May 06, 2021 / 12:00PM GMT
Release Date Price: $1018.75 (-7.91%)
Operator

Good day, and thank you for standing by, and welcome to the Trevena First Quarter 2021 Financial Results Conference Call.

(Operator Instructions)

Please be advised that today's conference is being recorded.

(Operator Instructions)

I would now like to hand the conference over to Mr. Barry Shin, Chief Financial Officer. Please go ahead.

Barry Shin
Trevena, Inc. - Senior VP & CFO

Thanks, operator. Good morning, and welcome, everyone. With me today are Carrie Bourdow, our President and CEO; Bob Yoder, our Chief Commercial Officer; and our Chief Medical Officer, Mark Demitrack.

As a reminder, we'll be making forward-looking statements within the meaning of federal securities laws. These statements are subject to risks and uncertainties related to our business, including those covered in our filings with the SEC.

We undertake no obligation to update these statements beyond today. As I'm sure you recall, OLINVYK is indicated in adults for the management of acute pain severe enough to require an IV, opioid

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot